BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 35800046)

  • 1. PET/CT Radiomic Features: A Potential Biomarker for EGFR Mutation Status and Survival Outcome Prediction in NSCLC Patients Treated With TKIs.
    Yang L; Xu P; Li M; Wang M; Peng M; Zhang Y; Wu T; Chu W; Wang K; Meng H; Zhang L
    Front Oncol; 2022; 12():894323. PubMed ID: 35800046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiomics in Gastric Cancer: First Clinical Investigation to Predict Lymph Vascular Invasion and Survival Outcome Using
    Yang L; Chu W; Li M; Xu P; Wang M; Peng M; Wang K; Zhang L
    Front Oncol; 2022; 12():836098. PubMed ID: 35433451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additional value of metabolic parameters to PET/CT-based radiomics nomogram in predicting lymphovascular invasion and outcome in lung adenocarcinoma.
    Nie P; Yang G; Wang N; Yan L; Miao W; Duan Y; Wang Y; Gong A; Zhao Y; Wu J; Zhang C; Wang M; Cui J; Yu M; Li D; Sun Y; Wang Y; Wang Z
    Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):217-230. PubMed ID: 32451603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of pre-therapy
    Zhang J; Zhao X; Zhao Y; Zhang J; Zhang Z; Wang J; Wang Y; Dai M; Han J
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1137-1146. PubMed ID: 31728587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can CT Radiomics Detect Acquired T790M Mutation and Predict Prognosis in Advanced Lung Adenocarcinoma With Progression After First- or Second-Generation EGFR TKIs?
    Yang X; Fang C; Li C; Gong M; Yi X; Lin H; Li K; Yu X
    Front Oncol; 2022; 12():904983. PubMed ID: 35875167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using contrast-enhanced CT and non-contrast-enhanced CT to predict EGFR mutation status in NSCLC patients-a radiomics nomogram analysis.
    Yang X; Liu M; Ren Y; Chen H; Yu P; Wang S; Zhang R; Dai H; Wang C
    Eur Radiol; 2022 Apr; 32(4):2693-2703. PubMed ID: 34807270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An [
    Meng N; Feng P; Yu X; Wu Y; Fu F; Li Z; Luo Y; Tan H; Yuan J; Yang Y; Wang Z; Wang M
    Eur Radiol; 2024 Jan; 34(1):318-329. PubMed ID: 37530809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next-Generation Radiogenomics Sequencing for Prediction of EGFR and KRAS Mutation Status in NSCLC Patients Using Multimodal Imaging and Machine Learning Algorithms.
    Shiri I; Maleki H; Hajianfar G; Abdollahi H; Ashrafinia S; Hatt M; Zaidi H; Oveisi M; Rahmim A
    Mol Imaging Biol; 2020 Aug; 22(4):1132-1148. PubMed ID: 32185618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of
    Yang B; Ji H; Zhong J; Ma L; Zhong J; Dong H; Zhou C; Duan S; Zhu C; Tian J; Zhang L; Wang F; Zhu H; Lu G
    Front Oncol; 2020; 10():567160. PubMed ID: 33262942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET/CT Based EGFR Mutation Status Classification of NSCLC Using Deep Learning Features and Radiomics Features.
    Huang W; Wang J; Wang H; Zhang Y; Zhao F; Li K; Su L; Kang F; Cao X
    Front Pharmacol; 2022; 13():898529. PubMed ID: 35571081
    [No Abstract]   [Full Text] [Related]  

  • 11. Development and validation of a [
    Li M; Yao H; Zhang P; Zhang L; Liu W; Jiang Z; Li W; Zhao S; Wang K
    Eur Radiol; 2023 May; 33(5):3354-3365. PubMed ID: 36547676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiomics Analysis of PET and CT Components of
    Wang X; Lu Z
    Front Oncol; 2021; 11():638124. PubMed ID: 33928029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CT-based nomogram for early identification of T790M resistance in metastatic non-small cell lung cancer before first-line epidermal growth factor receptor-tyrosine kinase inhibitors therapy.
    Li Y; Lv X; Wang Y; Xu Z; Lv Y; Hou D
    Eur Radiol Exp; 2023 Nov; 7(1):64. PubMed ID: 37914925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Machine Learning-Based CT Radiomics Analysis for Prognostic Prediction in Metastatic Non-Small Cell Lung Cancer Patients With
    Tang X; Li Y; Yan WF; Qian WL; Pang T; Gong YL; Yang ZG
    Front Oncol; 2021; 11():719919. PubMed ID: 34660285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a
    Liu H; Cui Y; Chang C; Zhou Z; Zhang Y; Ma C; Yin Y; Wang R
    BMC Cancer; 2024 Jan; 24(1):150. PubMed ID: 38291351
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Hu S; Kang Y; Xie Y; Yang T; Yang Y; Jiao J; Zou Q; Zhang H; Zhang Y
    Abdom Radiol (NY); 2023 Feb; 48(2):532-542. PubMed ID: 36370179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Potential of Radiomics Nomogram in Non-invasively Prediction of Epidermal Growth Factor Receptor Mutation Status and Subtypes in Lung Adenocarcinoma.
    Zhao W; Wu Y; Xu Y; Sun Y; Gao P; Tan M; Ma W; Li C; Jin L; Hua Y; Liu J; Li M
    Front Oncol; 2019; 9():1485. PubMed ID: 31993370
    [No Abstract]   [Full Text] [Related]  

  • 18. The predictive value of [
    Gao J; Niu R; Shi Y; Shao X; Jiang Z; Ge X; Wang Y; Shao X
    EJNMMI Res; 2023 Apr; 13(1):26. PubMed ID: 37014500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting EGFR mutation subtypes in lung adenocarcinoma using
    Liu Q; Sun D; Li N; Kim J; Feng D; Huang G; Wang L; Song S
    Transl Lung Cancer Res; 2020 Jun; 9(3):549-562. PubMed ID: 32676319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Machine learning based on clinico-biological features integrated
    Ren C; Zhang J; Qi M; Zhang J; Zhang Y; Song S; Sun Y; Cheng J
    Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1538-1549. PubMed ID: 33057772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.